Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex

Journal of Neuroscience Research

Volumn 73, Issue 5, 2003, Pages 708-716

  Martinez Rodriguez R ^a   Toledano, A ^b   Alvarez M I ^b   Turegano L ^a   Colman, O ^a   Roses P ^b   Gomez de Segura I ^a   De Miguel, E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Alzheimer's disease treatment; Astroglia; Brain cortex; Neurons; Nicotine

Indexed keywords

NERVE GROWTH FACTOR; NICOTINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENDRITIC CELL; ELECTRON MICROSCOPY; FRONTAL CORTEX; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROGLIA; MALE; NERVE DEGENERATION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CEREBRAL CORTEX; GANGLIONIC STIMULANTS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; NERVE GROWTH FACTOR; NEURONS; NICOTINE; RATS;

EID: 0041837469     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10688     Document Type: Article

References (70)

1. Albuquerque EX, Pereira EF, Mike A, Eisenberg HM, Maelicke A, Alkondon M. 2000. Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. Behav Brain Res 113:131-141.
2. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. 2000. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 20:66-75.
3. Barazangi N, Role LW. 2001. Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. J Neurophysiol 86:463-474.
4. Bartus RT. 2000. On neurodegenerative disease models and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529.
5. Bartus RT, Dean RL, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-417.
6. Bergado JA, Gomez-Soria AA, Cruz R, Fernandez CI. 1998. Nerve growth factor improves evoked potentials and long-term potentiation in the dentate gyrus of presenile rats. Eur J Pharmacol 345:181-184.
7. Blochl A, Thoenen H. 1995. Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur J Neurosci 7:1220-1228.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Brown RW, Kolb B. 2001. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 899:94-100.
10. Buisson B, Mertrand D. 2002. Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23:130-136.
11. Carlson J, Noguchi K, Ellison G. 2001. Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus. Brain Res 906:127-134.
12. Casamenti F, Scali C, Giovannelli L, Faussone-Pellegrini MS, Pepeu G. 1994. Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after lesion of the nucleus basalis in aging rats. J Neural Transm Park Dis Dement Sect 7:177-193.
13. Changeux JP, Bertrand D, Corringer PJ, Dehaene S, Edelstein S, Lena C, Le Novere N, Marubio L, Picciotto M, Zoli M. 1998. Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res Brain Res Rev 26:198-216.
14. Chédotal A, Umbriaco D, Descarries L, Hartman BK, Hamel E. 1994. Light and electron microscopic immunocytochemical analysis of the neurovascular relationships of cholinacetyltransferase and vasoactive intestinal peptide nerve terminals in the rat cerebral cortex. J Comp Neurol 343:57-71.
15. Conner JM, Varon S. 1992. Distribution of nerve growth factor-like immunoreactive neurons in the adult rat brain following colchicine treatment. J Comp Neurol 326:347-362.
16. Cordero-Erausquin M, Marubio LM, Klink R, Changeux JP. 2000. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21:211-217.
17. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. 2001. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49:175-184.
18. Coyle JT, Price DL, Delong MR. 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 217:1184-1190.
19. Dani JA, Ji D, Zhou FM. 2001. Synaptic plasticity and nicotine addiction. Neuron 31:349-352.
20. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK. 2000. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38:313-321.
21. Fahnestock M, Michalski B, Xu B, Coughlin MD. 2001. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18:210-220.
22. French SJ, Humby T, Horner CH, Sofroniew MV, Rattray M. 1999. Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine carbachol and pilocarpine. Brain Res Mol Brain Res 67:124-136.
23. Fuji S, Sumikawa K. 2001. Acute and chronic nicotine exposure reverse age-related decline in the induction of long-term potentiation in the rat hippocampus. Brain Res 894:347-353.
24. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. 1996. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716.
25. Gu Z, Yu J, Perez-Polo R. 1998. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion. Brain Res 801:190-197.
26. Greene LA, Shooter EM. 1980. The nerve growth factor: biochemistry, synthesis, and mechanism of action. Ann Rev Neurosci 3:353-402.
27. Hefti F. 1994. Development of effective therapy for Alzheimer's disease based on neurotrophic factors. Neurobiol Aging 2(Suppl):193-194.
28. Hefti F, Dravid A, Hartikka J. 1984. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293:305-311.
29. Hellweg R, Humpel C, Lowe A, Hortnag IH. 1997. Moderate lesion of the rat cholinergic septohippocampal nerve growth factor synthesis: evidence for long-term compensatory changes? Brain Res Mol Brain Res 45:177-181.
30. Iversen SD. 1998. The pharmacology of memory. C R Acad Sci III 321:209-215.
31. Ji D, Lope R, Dani JA. 2001. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31:131-141.
32. Jonnala RR, Buccafusco JJ. 2001. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 66:565-572.
33. Kalaria RN, Homayoun P, Whitehouse PJ. 1994. Nicotinic cholinergic receptors associated with mammalian cerebral vessels. J Auton Nerv Syst 49(Suppl):3-7.
34. Katoh-Semba R, Takeuchi IK, Kato K. 1998. Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Neurosci Res 31:227-234.
35. Kenny PJ, File SE, Rattray M. 2000. Acute nicotine decreases and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234-238.
36. Knipper M, da Penha Berzaghi M, Blochl A, Breer H, Thoenen H, Lindholm D. 1994. Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain derived neurotrophic factor in the rat hippocampus. Eur J Neurosci 4:668-671.
37. Levin ED, Simon BB. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138:217-230.
38. Li Y, Papke RL, He YL, Millard WJ, Meyer EM. 1999. Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells. Brain Res 830:218-225.
39. Lindstrom J, Anand R, Peng X, Gerzanich V, Wang F, Li Y. 1995. Neuronal nicotinic receptor subtypes. Ann N Y Acad Sci 757:100-116.
40. Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chá vez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA. 1998. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci 62:1601-1606.
41. Lloyd GK, Williams M. 2000. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Neurol 292:461-467.
42. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. 1998. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287:435-439.
43. Maelicke A. 2000. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease. Dement Geriatr Cogn Disord 11:11-18.
44. Maelicke A, Schrattenholz A, Samochocki M, Radina M, Albuquerque EX. 2000. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav Brain Res 113:199-206.
45. Mansvelder HD, Keath JR, McGehee DS. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905-919.
46. Martínez-Serrano A, Björklund A. 1998. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc Natl Acad Sci USA 95:1858-1863.
47. Nishio T, Furukawa S, Akiguchi I, Oka N, Ohnishi K, Tomimoto H, Nakamura S, Kimura J. 1994. Cellular localization of nerve growth factor-like immunoreactivity in adult rat brain: quantitative and immunohistochemical study. Neuroscience 60:67-84.
48. Nonner D, Barrett EF, Barrett JN. 2000. Brief exposure to neurotrophins produces a calcium-dependent increase in choline acetyltransferase activity in cultured rat septal neurons. J Neurochem 74:268-278.
49. Oderfeld-Nowak B, Bacia A, Gradkowska M, Fuxo M, Vantani G, Leon A, Aloe L. 1992. In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules. Neurochem Int 21:455-461.
50. Olson L, Nordberg A, von Holst H, Backman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, et al. 1992. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient. J NeuraI Transm Park Dement Sect 4:79-95.
51. Paterson D, Nordberg A. 2000. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-11.
52. Radcliffe KA, Dani JA. 1998. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18:7075-7083.
53. Rattray M. 2001. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol Psychiatry 49:185-193.
54. Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. 1998. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol 56:541-569.
55. Rossner S, Wortwein G, Gu Z, Yu J, Schliebs R, Bigl V, Perez-Polo RJ. 1997. Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment. J Neurochem 69:947-953.
56. Scott SA, Crutcher KA. 1994. Nerve growth factor and Alzheimer's disease. Rev Neurosci 5:179-211.
57. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. 1995. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213-6221.
58. Seiler M, Schwab ME. 1984. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 300:33-39.
59. Senut MC, Lamour Y, Lee J, Brachet P, Dicou E. 1990. Neuronal localization of the nerve growth factor precursor-like immunoreactivity in the rat brain. Int J Dev Neurosci 8:65-80.
60. Shimohama S, Akaike A, Kimura J. 1996. Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann N Y Acad Sci 777:356-361.
61. Siegel GJ, Chauhan NB. 2000. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 33:199-227.
62. Sihver W, Gillberg PG, Nordberg A. 1998. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H]-(-)nicotine, [3H]cystisine and [3H] epibatidine in vitro autoradiography. Neuroscience 85:1121-1133.
63. Sofroniew MV, Howe CL, Mobley WC. 2001. Nerve growth factor signaling neuroprotection and neuronal repair. Annu Rev Neurosci 24:1217-1281.
64. Sternberger LA. 1979. Immunocytochemistry. 2nd ed. New York: John Wiley and Sons. p 104-169.
65. Sugaya K, Giacobini E, Chiappinelli VA. 1990. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J Neurosci Res 27:349-359.
66. Toledano A. 1994. Growth factors and aging factors in Alzheimer's disease In: Selmes S, Selmes J, Portera A, Toledano A, editors. Updating of Alzheimer's disease. Madrid: Fundación Alzheimer España/Alzheimer Europa/Meditor. p 59-71.
67. Turégano L, Martínez-Rodríguez R, Álvarez MI, Gragera RR, Gómez de Segura A, De Miguel E, Toledano A. 2001. Histochemical study of acute and chronic intraperitoneal effects on several glycolytic and Krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain. J Neurosci Res 64:626-635.
68. Van der Zee CE, Lourenssen S, Stanisz J, Diamond J. 1995. NGF deprivation of adult rat brain results in cholinergic hypofunction and selective impairments in spatial learning. Eur J Neurosci 7:160-168.
69. Yu J, Willey RG, Pérez-Polo RJ. 1996. Altered NGF protein levels in different brain areas after immunolesion. J Neurosci Res 43:213-223.
70. Zoli M, Léna C, Picciotto MR, Changeux JP. 1998. Identification of four classes of brain nicotine receptors using beta2 mutant mice. J Neurosci 18:4461-4472.